Buying advanced medical equipment is expensive. Maintaining it, training staff and replacing ageing technology make the decision harder still. EASE wants healthcare providers to pay for use and service rather than carry every cost of ownership themselves.
The equipment-as-a-service company announced $9.5 million in additional equity on 4 November 2026. The investor is AAFC Group Inc, a US-based company active in emerging-market asset-backed finance. EASE said the raise brought its total equity capital to $24 million.
Its focus is South Africa and Ghana, with the company aiming to broaden access to advanced medical imaging and surgical equipment, including increasingly AI-enabled technologies. The new equity will work alongside existing debt facilities, according to the announcement.
Why pay-per-use can change a hospital’s purchasing decision
A hospital that purchases a scanner outright assumes the full initial cost and many of the risks attached to maintenance, repair and eventual replacement. Under EASE’s model, customers can access equipment and related maintenance, technical support and upgrades through a managed service.
That can transform the purchasing decision from a large capital project into a recurring operating expense. It also places obligations on EASE: the company’s economics depend on buying and financing the equipment, maintaining uptime and recovering service payments over time.
The structure is not automatically cheaper for every facility. The total cost depends on utilisation, contract terms and the length of the arrangement. EASE’s announcement does not disclose a standard customer tariff or enough information to calculate savings for individual hospitals.
South Africa is the nearer-term target
EASE says it is targeting at least $20 million in new South African equipment installations during 2027. That is a company target, not a completed deployment. The announcement also identifies Ghana as an expansion market but does not provide a comparable installation target there.
For health systems, the value of an imaging or surgical device is measured by useful patient access, appropriate clinical use and reliable operation, not simply the number of machines delivered. AI-enhanced capabilities may improve certain workflows, but the announcement does not prove better patient outcomes or establish the performance of any specific AI model.
This raise is an equity financing for a managed-equipment company, not a grant to hospitals. Its next substantive milestones will be signed installations, functioning equipment, service uptime and evidence that providers can sustain the recurring costs. If EASE delivers those, its model could make expensive healthcare technology available to facilities that would otherwise postpone purchases.






